Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3102-3108

  Ramakrishna, C ^a   Desai, Anita ^a   Shankar, S K ^a   Chandramuki, A ^a   Ravi, V ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Japanese encephalitis virus; Oral immunisation; Protection

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033529662     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00137-1     Document Type: Article

References (17)

1. Umenai T., Krzysko R., Bektimirov T.A., Assad F.A. Japanese encephalitis: current worldwide status. Bull WHO. 63:1985;625-631.
2. Dhanda V., Thenmozhi V., Kumar N.P., Hiriyan J., Arunachalam N., Balasubramaniam A., Illango A., Gajanana A. Virus isolation from wild caught mosquitoes during JE outbreak in Kerala in 1996. Indian J Med Res. 106:1997;4-6.
3. Rao Bhao K.N., Singh G., Gowal D., Saxena S.N., Kobayashi M., Oya A., Yoshioka I. Safety and efficacy of Japanese Encephalitis vaccine produced in India. Indian J Med Res. 88:1988;301-307.
4. Anderson M.M., Ronne T. Side effects with Japanese Encephalitis vaccine. Lancet. 337:1991;1044.
5. Ruff T.A., Eisen D., Fuller A., Kass R. Adverse reactions to Japanese Encephalitis vaccine. Lancet. 338:1991;881-882.
6. Ohtaki E., Matsuishi T., Hirano Y., Maekawa K. Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine Nakayama-Yoken and Beijing strains. J Neurol Neurosurg Psychiatry. 59:1995;316-317.
7. Fukuda H., Umehara F., Kawahigashi N., Suehara M., Osame N. Acute disseminated myelitis after Japanese B encephalitis vaccination. J Neurol Sci. 148:1997;113-115.
8. Plesner A.M., Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine. 15:1997;1239-1243.
9. 14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine. 6:1988;513-518.
10. 14-14-2): a case controlled study. Lancet. 347:1996;1583-1586.
11. Clarke D.H., Cassals J. Techniques of haemagglutination and haemagglutination inhibition with arthropod borne viruses. Am J Trop Med Hyg. 7:1958;561-573.
12. Desai A., Ravi V., Chandramuki A., Gourie-Devi M. Detection of neutralizing antibodies to Japanese encephalitis virus in the cerebrospinal fluid using a rapid microneutralization test. Serodiagn Immunother Infect Disease. 6:1994;130-134.
13. Walker R.J. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12:1994;387-400.
14. Kieny M.P., Lathe R., Drillen R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J.P. Expression of Rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 312:1984;163-166.
15. Mason H.S., Lam D.M., Arutzen C.J. Expression of Hepatitis B surface antigen in transgeneic plants. Proc Natl Acad Sci USA. 89:1992;11,745-11,749.
16. McGarvey P.B., Hammond J., Dinelt M.M., Hooper D.C., Fu Z.F., Dietzschold B., Koprowski H., Michaels F.H. Expression of the rabies virus glycoprotein in transgeneic tomatoes. Biotechnology. 13:1995;1487-1585.
17. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Hiroshi K. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:1992;75-78.